A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03350542
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03350542
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Latvia, New Zealand, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03350542. Allocation not applicable; no masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2020-01-16 (actual). Results posted on 2021-02-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
- Acronym
- EVOLVE48
- Condition
- Coronary Artery Disease
- Intervention (Device)
- SYNERGY 48 mm
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct03350542- Content hash
22e1a0a913f707497214a35663d0932a91a4d8c0c5c7b364894eea51a88e7f35